| Literature DB >> 26217080 |
Michael Hollis1, Kavitha Nair1, Arpita Vyas1, Lakshmi Shankar Chaturvedi1, Sahil Gambhir1, Dinesh Vyas1.
Abstract
Over the past decade, research has shown that aberrant expression of microRNA (miRNA) is involved in colorectal cancer development and progression. MicroRNAs are small sequences of non-coding RNA that regulate expression of genes involved in important cellular functions, such as cell differentiation, multiplication, and apoptosis. A specific miRNA may display the effects of a tumor suppressor or oncogene. Altered miRNA expression is found in colorectal cancer (CRC) and patterns of miRNA expression correlate with CRC detection and outcome. Studies also have examined the use of circulating serum miRNA and fecal miRNA expression as non-invasive markers for early detection. Here, we review recent evidence demonstrating the potential role of miRNA in CRC and the implications of its use in the diagnosis, prognosis, and management of CRC.Entities:
Keywords: Colorectal cancer; Diagnostic; Expression; Fecal microRNA; MicroRNA; Prognostic; Serum microRNA; Therapeutic
Mesh:
Substances:
Year: 2015 PMID: 26217080 PMCID: PMC4507098 DOI: 10.3748/wjg.v21.i27.8284
Source DB: PubMed Journal: World J Gastroenterol ISSN: 1007-9327 Impact factor: 5.742